Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia by Castillo, Jorge J., Sarosiek, Shayna, Branagan, Andrew R., Sermer, David J., Flynn, Catherine A., Leventoff, Carly, Little, Megan, White, Timothy P, Meid, Kirsten, Canning, Alexa, Guerrera, Maria Luisa, Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, Patterson, Christopher J, Hunter, Zachary R, Treon, Steven P

Get full text

The ERK1/2 Regulator WNK2 Shows Novel Alternative Splicing Aberrations That Support Tumor Growth in MYD88 Mutated Waldenström's Macroglobulinemia by Guerrera, Maria Luisa, Liu, Xia, Morelli, Eugenio, Richardson, Kris, Tsakmaklis, Nickolas, Kofides, Amanda, Munshi, Manit, Liu, Shirong, Yang, Guang, Patterson, Christopher J, Castillo, Jorge J., Sarosiek, Shayna, Flynn, Catherine A., Meid, Kirsten, Gustine, Joshua, Branagan, Andrew R., Trojani, Alessandra, Tedeschi, Alessandra, Cairoli, Roberto, Sewastianik, Tomasz, Carrasco, Ruben D., Anderson, Kenneth C., Munshi, Nikhil C, Treon, Steven P, Hunter, Zachary R

Get full text

Identification of Robust Predictors for Ibrutinib Response By Multi-Omic Genomics in MYD88 Mutated Waldenstrom's Macroglobulinemia by Richardson, Kris, Castillo, Jorge J., Sarosiek, Shayna, Branagan, Andrew R., Flynn, Catherine A., Meid, Kirsten, Leventoff, Carly, White, Timothy P, Little, Megan, Gustine, Joshua, Liu, Xia, Kofides, Amanda, Liu, Shirong, Canning, Alexa, Wolf, Julie, Kacena, Katherine, Patterson, Christopher J, Guerrera, Maria Luisa, Tsakmaklis, Nickolas, Treon, Steven P, Hunter, Zachary R

Get full text

Multi-Omic Analysis of 253 Untreated Patients with Waldenström's Macroglobulinemia Reveals Clinically and Genomically Distinct Disease Subtypes and a Model for Disease Progression by Hunter, Zachary R, Tsakmaklis, Nickolas, Richardson, Kris, Guerrera, Maria Luisa, Kofides, Amanda, Liu, Xia, Liu, Shirong, Canning, Alexa, Munshi, Manit, Sarosiek, Shayna, Flynn, Catherine A., Branagan, Andrew R., Xu, Lian, Yang, Guang, Meid, Kirsten, Gustine, Joshua, Patterson, Christopher J, Anderson, Kenneth C., Munshi, Nikhil C, Castillo, Jorge J., Treon, Steven P

Get full text

Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next generation sequencing in Waldenström macroglobulinemia by Gustine, Joshua N., Xu, Lian, Yang, Guang, Liu, Xia, Kofides, Amanda, Tsakmaklis, Nicholas, Munshi, Manit, Demos, Maria, Guerrera, Maria Luisa, Meid, Kirsten, Patterson, Christopher J., Sarosiek, Shayna, Branagan, Andrew R., Hunter, Zachary R., Castillo, Jorge J., Treon, Steven P.

Get full text

A New Role for the SRC Family Member HCK As a Driver of BCR/SYK Signaling in MYD88 Mutated Lymphomas by Munshi, Manit, Liu, Xia, Kofides, Amanda, Tsakmaklis, Nickolas, Demos, Maria G, Guerrera, Maria Luisa, Hunter, Zachary R, Palomba, M. Lia, Argyropoulos, Kimon V., Patterson, Christopher J, Meid, Kirsten, Gustine, Joshua, Castillo, Jorge J., Sarosiek, Shayna, Flynn, Catherine A, Wang, Jinhua, Buhrlage, Sara J, Gray, Nathanael S, Munshi, Nikhil C., Anderson, Kenneth C., Yang, Guang, Treon, Steven P

Get full text

The ERK1/2 Regulator WNK2 Shows Differential Expression and Isoform Usage, Primarily Driven By Aberrant Methylation, in MYD88 Mutated Waldenström's Macroglobulinemia by Guerrera, Maria Luisa, Yang, Guang, Liu, Xia, Tsakmaklis, Nickolas, Demos, Maria G, Kofides, Amanda, Munshi, Manit, Xu, Lian, Patterson, Christopher J, Castillo, Jorge J., Sarosiek, Shayna, Flynn, Catherine A, Meid, Kirsten, Gustine, Joshua, Sewastianik, Tomasz, Carrasco, Ruben D., Treon, Steven P, Hunter, Zachary R

Get full text

Pirtobrutinib (LOXO-305) Is Active and Overcomes ERK Related Pro-Survival Signaling in Ibrutinib Resistant, BTK Cys481 Mutant Expressing WM and ABC DLBCL Lymphoma Cells Driven By A... by Munshi, Manit, Liu, Xia, Kofides, Amanda, Tsakmaklis, Nickolas, Gustine, Joshua, Sarosiek, Shayna, Flynn, Catherine A, Meid, Kirsten, White, Timothy P, Leventoff, Carly, Patterson, Christopher J, Branagan, Andrew R., Gokhale, Prafulla, Poitras, Michael J, Hunter, Zachary R, Guerrera, Maria Luisa, Castillo, Jorge J., Yang, Guang, Treon, Steven P

Get full text

Somatic Variants Associated with MDS/AML Are Present in MYD88 Mutated Waldenstrom's Macroglobulinemia by Chan, Gloria, Gustine, Joshua, Tsakmaklis, Nickolas, Xu, Lian, Kofides, Amanda, Demos, Maria, Treon, Steven P, Hunter, Zachary

Get full text

Mutated MYD88 Regulates HCK Pro-Survival Signaling through JunB in MYD88 Mutated B-Lymphoma Cells by Liu, Xia, Chen, Jiaji G, Munshi, Manit, Xu, Lian, Kofides, Amanda, Tsakmaklis, Nicholas, Demos, Maria, Guerrera, Maria Luisa, Chan, Gloria G, Jimenez, Cristina, Hunter, Zachary R, Patterson, Christopher, Meid, Kirsten, Keezer, Andrew, Castillo, Jorge J., Treon, Steven P, Yang, Guang

Get full text

CXCR4 Mutational Status Does Not Impact Outcomes in Patients with Waldenstrom Macroglobulinemia Treated with Proteasome Inhibitors by Castillo, Jorge J., Gustine, Joshua, Demos, Maria, Keezer, Andrew, Meid, Kirsten, Dubeau, Toni, Chan, Gloria G, Chen, Jiaji, Guerrera, Maria Luisa, Kofides, Amanda, Munshi, Manit, Tsakmaklis, Nicholas, Liu, Xia, Xu, Lian, Yang, Guang, Hunter, Zachary R, Treon, Steven P

Get full text

Clinical and Genomic Factors Are Predictive of Response and Prognostic of Progression-Free Survival in Patients with Waldenström Macroglobulinemia Treated with Ibrutinib by Castillo, Jorge J., Gustine, Joshua, Demos, Maria, Keezer, Andrew, Meid, Kirsten, Chan, Gloria G, Chen, Jiaji G, Guerrera, Maria Luisa, Kofides, Amanda, Munshi, Manit, Tsakmaklis, Nicholas, Liu, Xia, Xu, Lian, Yang, Guang, Hunter, Zachary R, Treon, Steven P

Get full text

Genomic Evolution of Ibrutinib Resistant Clones in Waldenström Macroglobulinemia by Jiménez, Cristina, Chan, Gloria G., Xu, Lian, Tsakmaklis, Nickolas, Kofides, Amanda, Demos, Maria G., Chen, Jiaji, Liu, Xia, Munshi, Manit, Yang, Guang, Castillo, Jorge J., Wiestner, Adrian, García- Sanz, Ramón, Treon, Steven P., Hunter, Zachary R.

Get full text

Partial response or better at six months is prognostic of superior progression‐free survival in Waldenström macroglobulinaemia patients treated with ibrutinib by Castillo, Jorge J., Abeykoon, Jithma P., Gustine, Joshua N., Zanwar, Saurabh, Mein, Kirsten, Flynn, Catherine A., Demos, Maria G., Guerrera, Maria L., Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nickolas, King, Rebecca, Yang, Guang, Hunter, Zachary R., Advani, Ranjana H., Palomba, Maria Lia, Ansell, Stephen M., Gertz, Morie A., Kapoor, Prashant, Treon, Steven P.

Get full text

Cell‐free DNA analysis for detection of MYD88L265P and CXCR4S338X mutations in Waldenström macroglobulinemia by Demos, Maria G., Hunter, Zachary R., Xu, Lian, Tsakmaklis, Nicholas, Kofides, Amanda, Munshi, Manit, Liu, Xia, Guerrera, Maria Luisa, Leventoff, Carly R., White, Timothy P., Flynn, Catherine A., Meid, Kirsten, Patterson, Christopher J., Yang, Guang, Branagan, Andrew R., Sarosiek, Shayna, Castillo, Jorge J., Treon, Steven P., Gustine, Joshua N.

Get full text

Partial response or better at 6 months is prognostic of superior progression-free survival in Waldenstrom macroglobulinemia patients treated with ibrutinib by Castillo, Jorge J., Abeykoon, Jithma P., Gustine, Joshua N., Zanwar, Saurabh, Mein, Kirsten, Flynn, Catherine A., Demos, Maria G., Guerrera, Maria L., Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nickolas, King, Rebecca, Yang, Guang, Hunter, Zachary R., Advani, Ranjana H., Palomba, M. Lia, Ansell, Stephen M., Gertz, Morie A., Kapoor, Prashant, Treon, Steven P.

Get full text

Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia by Hunter, Zachary R., Xu, Lian, Tsakmaklis, Nickolas, Demos, Maria G., Kofides, Amanda, Jimenez, Cristina, Chan, Gloria G., Chen, Jiaji, Liu, Xia, Munshi, Manit, Gustine, Joshua, Meid, Kirsten, Patterson, Christopher J., Yang, Guang, Dubeau, Toni, Samur, Mehmet K., Castillo, Jorge J., Anderson, Kenneth C., Munshi, Nikhil C., Treon, Steven P.

Get full text

CXCR4 mutational status does not impact outcomes in patients with Waldenström macroglobulinemia treated with proteasome inhibitors by Castillo, Jorge J., Gustine, Joshua N., Meid, Kirsten, Flynn, Catherine A., Demos, Maria G., Guerrera, Maria L., Jimenez, Cristina, Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, Patterson, Christopher J., Xu, Lian, Yang, Guang, Hunter, Zachary R., Treon, Steven P.

Get full text

Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-up by Castillo, Jorge J., Meid, Kirsten, Flynn, Catherine A., Chen, Jiaji, Demos, Maria G., Guerrera, Maria L., Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, Patterson, Christopher J., Yang, Guang, Hunter, Zachary, Treon, Steven P.

Get full text

A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia by Castillo, Jorge J., Itchaki, Gilad, Gustine, Joshua N., Meid, Kirsten, Flynn, Catherine A., Demos, Maria G., Guerrera, Maria L., Jimenez, Cristina, Kofides, Amanda, Liu, Xia, Munshi, Manit, Tsakmaklis, Nicholas, Patterson, Christopher J., Xu, Lian, Yang, Guang, Hunter, Zachary R., Treon, Steven P.

Get full text